Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
Hera Saqub(California Pacific Medical Center), Altaf A. Dar(Vanderbilt University Medical Center)
Cited by 89
Related Papers
Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?
|Molecular Cancer Therapeutics|2010|248
Aurora Kinase A Inhibition Leads to p73-Dependent Apoptosis in p53-Deficient Cancer Cells
|Cancer Research|2008|117
Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions
|Cancer|2008|110
Tumor suppressor role of microRNA-1296 in triple-negative breast cancer
|Oncotarget|2016|64
Novel tumor suppressor role of miRNA-876 in cholangiocarcinoma
|Oncogenesis|2019|51